ch and biomanufacturing to deliver innovative biomedicines that transform patients' lives.
The world leader in monoclonal antibody production and technology, Centocor has brought critical biologic therapies to patients suffering from debilitating immune disorders. More information about Centocor is available at www.centocor.com.
1. Manhattan Research 2007 Rheumatoid Arthritis Patient Study, Slide 121
2. Manhattan Research 2007 Rheumatoid Arthritis Patient Study, Slide 31
3. Manhattan Research 2007 Rheumatologist Study, Years in Practice Reference Deck, Slide 72
4. Manhattan Research 2007 Rheumatoid Arthritis Patient Study, Slide 147
5. Manhattan Research 2007 Rheumatoid Arthritis Patient Study, Slide 144
6. Manhattan Research 2007 Rheumatoid Arthritis Patient Study, Slide 142
7. Manhattan Research 2007 Rheumatoid Arthritis Patient Study, Slide 28
8. Manhattan Research 2007 Rheumatoid Arthritis Patient Study, Slide 104
Media Contact:
Brian Kenney
Centocor, Inc.
Phone: 215-325-2107
Mobile: 215-620-0111
###
'/>"/>Source: PRWeb Copyright©2008 Vocus, Inc. All rights reserved | |
Page: 1 2 3 4 5 Related medicine news :1.
Survey reveals disparities in skin cancer knowledge, protection among high school students2.
New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat3.
One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High4.
Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey5.
Youth Drug Use at a Five Year Low, New Survey Shows6.
Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives7.
Parental surveys boost diagnosis abilities of pediatricians8.
National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline9.
JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results10.
PA Health Department Survey Shows Impact of Income, Gender, Other Factors on Health and Access to Health Care11.
Launch of second European Cancer Research Funding survey